High mobility group box chromosomal protein 1 in patients with renal diseases

Nephron - Clinical Practice

Volumn 108, Issue 3, 2008, Pages

  Sato, Fumihiko ^a   Maruyama, Shoichi ^a   Hayashi, Hiroki ^a   Sakamoto, Izumi ^a   Yamada, Shingo ^b   Uchimura, Tomonori ^c   Morita, Yoshiki ^a   Ito, Yasuhiko ^a   Yuzawa, Yukio ^a   Maruyama, Ikuro ^c   Matsuo, Seiichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINO TEST CORPORATION   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Antineutrophil cytoplasmic antibody; Crescentic glomerulonephritis; Cytokines; Henoch Sch nlein purpura; IgA nephropathy; Inflammation; Vasculitis

Indexed keywords

CHROMOSOME PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANAPHYLACTOID PURPURA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY INTERSTITIUM; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VASCULITIS; WESTERN BLOTTING;

HMGB1 PROTEIN; HUMANS; KIDNEY; KIDNEY DISEASES;

EID: 42549121715     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118942     Document Type: Article

References (31)

1. Paonessa G, Frank R, Cortese R: Nucleotide sequence of rat liver HMG1 cDNA. Nucleic Acids Res 1987;15:9077.
2. Ferrari S, Ronfani L, Calogero S, Bianchi ME: The mouse gene coding for high mobility group 1 protein (HMG1). J Biol Chem 1994;269:28803-28808.
3. Wen L, Huang JK, Johnson BH, Reeck GR: A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res 1989;17:1197-1214.
4. Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-5246.
5. Hori O, Brett J, Slattery T, et al: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752-25761.
6. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354-360.
7. Fages C, Nolo R, Huttunen HJ, Eskelinen E, Rauvala H: Regulation of cell migration by amphoterin. J Cell Sci 2000;113:611-620.
8. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
9. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002;72:1084-1091.
10. Yang H, Wang H, Tracey KJ: HMG-1 rediscovered as a cytokine. Shock 2001;15:247-253.
11. Erlandsson Harris H, Andersson U: Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004;34:1503-1512.
12. Wang H, Yang H, Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004;255:320-331.
13. Ombrellino M, Wang H, Ajemian MS, Talhouk A, Scher LA, Friedman SG, Tracey KJ: Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 1999;354:1446-1447.
14. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I: High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003;48:971-981.
15. Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y, Uemoto S, Yamada S, Maruyama I: Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost 2005;94:975-979.
16. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000;165:2950-2954.
17. Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, Ulloa L, Yang H, Yan XJ, Furie R, Chiorazzi N, Tracey KJ, Andersson U, Harris HE: High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002;46:2598-2603.
18. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005;201:1135-1143.
19. Watanabe T, Kubota S, Nagaya M, Ozaki S, Nagafuchi H, Akashi K, Taira Y, Tsukikawa S, Oowada S, Nakano S: The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res 2005;124:59-66.
20. Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, Nakao K: Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol 1998;25:703-709.
21. Sobajima J, Ozaki S, Uesugi H, Osakada F, Shirakawa H, Yoshida M, Nakao K: Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (PANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin Exp Immunol 1998;111:402-407.
22. Sobajima J, Ozaki S, Uesugi H, Osakada F, Inoue M, Fukuda Y, Shirakawa H, Yoshida M, Rokuhara A, Imai H, Kiyosawa K, Nakao K: High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999;44:867-873.
23. Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I: High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 2003;49:1535-1537.
24. Yamada S, Yakabe K, Ishii J, Imaizumi H, Maruyama I: New high mobility group box 1 assay system. Clin Chim Acta 2006;372:173-178.
25. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH Jr, Kull FC Jr, Gonzalez-Cadavid N: Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 2001;280:E221-E228.
26. Davin JC, Ten Berge IJ, Weening JJ: What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 2001;59:823-834.
27. Degryse B, Bonaldi T, Scaffidi P, Müller S, Resnati M, Sanvito F, Arrigoni G, Bianchi ME: The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001;152:1197-1206.
28. Mullins GE, Sunden-Cullberg J, Johansson AS, Rouhiainen A, Erlandsson-Harris H, Yang H, Tracey KJ, Rauvala H, Palmblad J, Andersson J, Treutiger CJ: Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol 2004;60:566-573.
29. Reinhart K, Bayer O, Brunkhorst F, Meisner M: Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002;30(5 Suppl):S302-S312.
30. Bradley JR, Lockwood CM, Thiru S: Endothelial cell activation in patients with systemic vasculitis. QJM 1994;87:741-745.
31. Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A, Cossu G, Bianchi ME: Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 2004;164:441-449.